MedTrace Logo

Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis

NCT01270412 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2011-07-19

No results posted yet for this study

Summary

Autologous platelet-secreted growth factors (GFs) may have therapeutic effects in osteoarthritis (OA) capsular joints via multiple mechanisms. The aim is to examine the effect of a platelet-derived preparation rich in growth factors (PRGFs) in OA of the knee.

Conditions

  • Osteoarthritis of the Knee

Interventions

BIOLOGICAL

Platelet Rich Plasma (Preparation Rich in Growth Factors)

intra articular injection 6ml

DRUG

Hyaluronic acid

Intra articular injections: 20 mg / 2 ml

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Lior Laver, MD · Meir Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-12-31
Completion
2013-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01270412 on ClinicalTrials.gov